Quality of life after cancer—How the extent of impairment is influenced by patient characteristics
Open Access
- 10 October 2016
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 16 (1) , 787
Abstract
Although this effect is well known, tailored treatment methods have not yet been broadly adopted. The aim of this study was to identify those patient characteristics that most influence the impairment of quality of life and thus to identify those patients who need and can benefit most from specific intervention treatment. 1879 cancer patients were given the EORTC QLQ C-30 questionnaire at the beginning and end of their inpatient rehabilitation. Patients’ scores were compared to those of 2081 healthy adults (Schwarz and Hinz, Eur J Cancer 37:1345–1351, 2001). Furthermore, differences in quality of life corresponding to sex, age, tumor site, TNM stage, interval between diagnosis and rehabilitation, and therapy method were examined. Compared to the healthy population, the study group showed a decreased quality of life in all analyzed domains. This difference diminished with increasing age. Women reported a lower quality of life then men in general. Patients with prostate cancer showed the least impairment in several domains. Patients having undergone chemotherapy as well as radiotherapy were impaired the most. Surprisingly, TNM stage and interval between diagnosis and rehabilitation did not significantly influence quality of life. Global quality of life and all functional domains significantly improved after a 3-week rehabilitation program. Despite an individualized and increasingly better tolerable therapy, the quality of life of cancer patients is still considerably impaired. However, systematic screening of psychosocial aspects of cancer, e.g. quality of life, could enable improved intervention.Keywords
This publication has 32 references indexed in Scilit:
- Impairment‐driven cancer rehabilitation: An essential component of quality care and survivorshipCA: A Cancer Journal for Clinicians, 2013
- Health-related quality of life does not differ between short-term, long-term and very long-term cancer survivors in the Swedish general populationPsycho-Oncology, 2012
- Impact of response shift on longitudinal quality-of-life assessment in cancer clinical trialsExpert Review of Pharmacoeconomics & Outcomes Research, 2011
- Health-related quality of life and cancer clinical trialsTherapeutic Advances in Medical Oncology, 2011
- Radiation therapy in the elderly: More side effects and complications?Critical Reviews in Oncology/Hematology, 2009
- The Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical TrialsJournal of Clinical Oncology, 2008
- Cancer-Related Fatigue: The Scale of the ProblemThe Oncologist, 2007
- The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancerCancer, 2005
- Cancer‐related fatigueCancer, 2003
- Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanomaEuropean Journal of Cancer, 1993